KRYSTAL PATRICK: Open Payments
NPI 1558997247 · TUSCALOOSA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,359 in 64 payments from 11 companies in 2025. Trend: 2023 $622 · 2024 $1,528 · 2025 $1,359
Food & beverage: $1,359
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $310 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $285 |
| Otsuka America Pharmaceutical, Inc. | 18 | $280 |
| E.R. Squibb & Sons, L.L.C. | 5 | $113 |
| Vanda Pharmaceuticals Inc. | 3 | $91 |
| Axsome Therapeutics, Inc. | 4 | $90 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $81 |
| Lundbeck LLC | 2 | $38 |
| Supernus Pharmaceuticals, Inc. | 2 | $34 |
| Alkermes, Inc. | 1 | $23 |
Products named: VRAYLAR, CAPLYTA, REXULTI, COBENFY, FANAPT, Auvelity, TRINTELLIX, ABILIFY MAINTENA.
Industry payments across AL — which companies pay providers there.
